“Skin Clearance and Itch Relief in Black or African American Patients With Moderate-to-Severe Atopic Dermatitis Treated With Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s615. https://doi.org/10.25251/9qs79351.